Often, a food-safe epoxy resin will indicate FDA approval on the company’s safety ... If you would like to mix with other products such as color and glitter, you will also need to understand ...

Some states have already moved to restrict some synthetic dyes and the FDA banned Red 3 from the nation’s food supply.

Several studies reported reduced itch severity and urticaria activity with dupilumab. The FDA approved dupilumab for the treatment of patients 12 years and older with chronic spontaneous urticaria ...

At 3 years, Opdivo plus Yervoy led to an overall survival rate of 38% in patients with unresectable or metastatic hepatocellular carcinoma, compared to 24% with lenvatinib or sorafenib monotherapy.

LONDON, April 17, 2025 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announces it has acquired the FDA-approved Abbreviated New Drug ...

A newly approved antibiotic to treat urinary tract ... including women and people of color. In an accompanying commentary, two European experts warned that gonorrhea bacteria may eventually ...

Dupilumab is now approved for CSU patients aged 12+ not controlled by H1 antihistamines, targeting IL-4 and IL-13 pathways. Phase 3 trials showed significant reductions in itch and urticaria ...

today announced the U.S. Food and Drug Administration (FDA) approval for the Simplera Sync™ sensor for use with the MiniMed™ 780G system. With this approval, the MiniMed™ 780G system now ...

You’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence in health care and medicine. Sign up to get it delivered in your ...

(RTTNews) - Medtronic plc. (MDT) announced the U.S. Food and Drug Administration approval for the Simplera Sync sensor for use with the MiniMed 780G system. The MiniMed 780G system now offers more ...

If a product that has orphan drug designation subsequently receives the first FDA approval for the disease or condition for which it has such designation, the product is entitled to orphan drug ...